DNMT1 and lung cancer: Mithramycin A, an antibiotic with potent antitumor activity, binds to sequences of GC-rich or CG-rich DNA and upregulates tumor suppressor genes’ expression by reducing the methylation of their promoters through binding and depleting the DNMT1 protein in lung cancer cells (163).